| Role for DNA damage signaling in pulmonary arterial hypertension J Meloche, A Pflieger, M Vaillancourt, R Paulin, F Potus, S Zervopoulos, ... Circulation 129 (7), 786-797, 2014 | 248 | 2014 |
| Bromodomain-containing protein 4: the epigenetic origin of pulmonary arterial hypertension J Meloche, F Potus, M Vaillancourt, A Bourgeois, I Johnson, L Deschamps, ... Circulation research 117 (6), 525-535, 2015 | 168 | 2015 |
| Autonomic nervous system involvement in pulmonary arterial hypertension M Vaillancourt, P Chia, S Sarji, J Nguyen, N Hoftman, G Ruffenach, ... Respiratory research 18, 1-15, 2017 | 145 | 2017 |
| Adaptation and remodelling of the pulmonary circulation in pulmonary hypertension M Vaillancourt, G Ruffenach, J Meloche, S Bonnet Canadian Journal of Cardiology 31 (4), 407-415, 2015 | 122 | 2015 |
| The unrecognized threat of secondary bacterial infections with COVID-19 M Vaillancourt, P Jorth MBio 11 (4), 10.1128/mbio. 01806-20, 2020 | 111 | 2020 |
| The Y chromosome plays a protective role in experimental hypoxic pulmonary hypertension S Umar, CM Cunningham, Y Itoh, S Moazeni, M Vaillancourt, S Sarji, ... American journal of respiratory and critical care medicine 197 (7), 952-955, 2018 | 58 | 2018 |
| Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights G Ruffenach, J Hong, M Vaillancourt, L Medzikovic, M Eghbali Respiratory research 21, 1-14, 2020 | 56 | 2020 |
| miRNAs in PAH: biomarker, therapeutic target or both? J Meloche, A Pflieger, M Vaillancourt, C Graydon, S Provencher, S Bonnet Drug discovery today 19 (8), 1264-1269, 2014 | 35 | 2014 |
| Striatal pre-enkephalin overexpression improves Huntington’s disease symptoms in the R6/2 mouse model of Huntington’s disease S Bissonnette, M Vaillancourt, SS Hebert, G Drolet, P Samadi PLoS One 8 (9), e75099, 2013 | 34 | 2013 |
| Pseudomonas aeruginosa mexR and mexEF Antibiotic Efflux Pump Variants Exhibit Increased Virulence M Vaillancourt, SP Limsuwannarot, C Bresee, R Poopalarajah, P Jorth Antibiotics 10 (10), 1164, 2021 | 27 | 2021 |
| Free Fatty Acid Receptor G-protein–coupled Receptor 40 Mediates Lipid Emulsion-induced Cardioprotection S Umar, J Li, K Hannabass, M Vaillancourt, CM Cunningham, S Moazeni, ... Anesthesiology 129 (1), 154-162, 2018 | 23 | 2018 |
| Oral 15-Hydroxyeicosatetraenoic Acid Induces Pulmonary Hypertension in Mice by Triggering T Cell–Dependent Endothelial Cell Apoptosis G Ruffenach, E O’Connor, M Vaillancourt, J Hong, N Cao, S Sarji, ... Hypertension 76 (3), 985-996, 2020 | 22 | 2020 |
| Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension S Umar, G Ruffenach, S Moazeni, M Vaillancourt, J Hong, C Cunningham, ... Journal of the American Heart Association 9 (2), e012063, 2020 | 19 | 2020 |
| Histological hallmarks and role of Slug/PIP axis in pulmonary hypertension secondary to pulmonary fibrosis G Ruffenach, S Umar, M Vaillancourt, J Hong, N Cao, S Sarji, S Moazeni, ... EMBO molecular medicine 11 (9), e10061, 2019 | 17 | 2019 |
| The unrecognized threat of secondary bacterial infections with COVID-19. mBio. 2020; 11 (4): e01806-2 M Vaillancourt, P Jorth PubMed Abstract| Publisher Full Text| Free Full Text, 2020 | 9 | 2020 |
| Experimental pulmonary hypertension is associated with neuroinflammation in the spinal cord M Vaillancourt, P Chia, L Medzikovic, N Cao, G Ruffenach, D Younessi, ... Frontiers in Physiology 10, 1186, 2019 | 6 | 2019 |
| A compensatory RNase E variation increases Iron Piracy and Virulence in multidrug-resistant Pseudomonas aeruginosa during Macrophage infection M Vaillancourt, ACM Galdino, SP Limsuwannarot, D Celedonio, ... PLoS pathogens 19 (4), e1010942, 2023 | 3 | 2023 |
| The unrecognized threat of secondary bacterial infections with COVID-19. mBio 11: e01806-20 M Vaillancourt, P Jorth | 3 | 2020 |
| Novel therapeutic approaches of pulmonary arterial hypertension S Tyagi, V Batra International Journal of Angiology 28 (02), 112-117, 2019 | 3 | 2019 |
| Siderophores promote cooperative interspecies and intraspecies cross-protection against antibiotics in vitro ACM Galdino, M Vaillancourt, D Celedonio, K Huse, Y Doi, JS Lee, ... Nature Microbiology, 1-16, 2024 | 2 | 2024 |
